UB Paderborn / Katalog / Suche / in CDI

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer

Annals of oncology, 2007-04, Vol.18 (4), p.738-744

2007

Volltextzugriff (PDF)

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study

Annals of oncology, 2005-12, Vol.16 (12), p.1898-1905

2005

Volltextzugriff (PDF)

Immune checkpoint inhibitor refractory colitis leading to total colectomy in a melanoma patient

Acta gastro-enterologica belgica, 2023-04, Vol.86 (2), p.371-373

2023

Volltextzugriff (PDF)

Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up

Journal of pediatric gastroenterology and nutrition, 2016-08, Vol.63 (2), p.253-258

2016

Volltextzugriff (PDF)

Safety and cost of infliximab for the treatment of belgian pediatric patients with Crohn's disease

Acta gastro-enterologica belgica, 2012-12, Vol.75 (4), p.425-431

2012

Volltextzugriff (PDF)

A Belgian Traveler Who Acquired Yellow Fever in The Gambia

Clinical infectious diseases, 2002-11, Vol.35 (10), p.e113-e116

2002

Volltextzugriff (PDF)

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab

Acta gastro-enterologica belgica, 2018-01, Vol.81 (1), p.15-21

2018

Volltextzugriff (PDF)

Profile of pediatric Crohn's disease in Belgium

Journal of Crohn's and colitis, 2013-12, Vol.7 (11), p.e588-e598

2013

Volltextzugriff (PDF)

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2010-02, Vol.138 (2), p.463-468

2010

Volltextzugriff (PDF)

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

Journal of Crohn's and colitis, 2013-03, Vol.7 (2), p.154-160

2013

Volltextzugriff (PDF)

397P R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer

Annals of oncology, 2021-09, Vol.32, p.S537-S537

2021

Volltextzugriff (PDF)

P694 Genetic predisposition and thiopurine-induced pancreatitis in inflammatory bowel disease patients

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S467-S467

2019

Volltextzugriff (PDF)

P603 Persistence of vedolizumab maintenance therapy: Findings from a Belgian registry

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S503-S504

2020

Volltextzugriff (PDF)

P600 Vedolizumab dose optimisation: Findings from a Belgian registry

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S501-S502

2020

Volltextzugriff (PDF)

Budd-Chiari syndrome likely related to a slimming drug preparation

Journal of hepatology, 1995-11, Vol.23 (5), p.626-627

1995

Volltextzugriff (PDF)

P131 Effectiveness and safety of vedolizumab maintenance therapy for inflammatory bowel disease: findings from a Belgian registry

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S153-S154

2019

Volltextzugriff (PDF)

P495 Efficacy of switching to infliximab in Crohn's disease patients with loss of response to adalimumab

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S274-S274

2014

Volltextzugriff (PDF)

P320 Factors determining therapeutic strategy at diagnosis and evolution of disease severity in a cohort of Belgian pediatric Crohn's disease patients (BELCRO)

Journal of Crohn's and colitis, 2012-02, Vol.6, p.S137-S137

2012

Volltextzugriff (PDF)

P246 Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease

Journal of Crohn's and colitis, 2012-02, Vol.6, p.S107-S107

2012

Volltextzugriff (PDF)

Phase I study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3552-3552

2006

Volltextzugriff (PDF)

A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3552-3552

2004

Volltextzugriff (PDF)

A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.3552-3552

2004

Volltextzugriff (PDF)

Immune checkpoint inhibitor refractory colitis leading to total colectomy in a melanoma patient

Acta gastro-enterologica Belgica, 2023, Vol.86 (2), p.371-373

2023

Volltextzugriff (PDF)

260 A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma: the RadiOxCape study

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S80-S80

2003

Volltextzugriff (PDF)

Résumés des communications du Groupe Européen de Pathologistes spécialisés en ponctions sous échoendoscopie digestive / Abstracts of European Pathology Group communications on EUS-FNA

Acta endoscopica, 2005-02, Vol.35 (1), p.121-129

2005

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer

Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study

Immune checkpoint inhibitor refractory colitis leading to total colectomy in a melanoma patient

Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up

Safety and cost of infliximab for the treatment of belgian pediatric patients with Crohn's disease

A Belgian Traveler Who Acquired Yellow Fever in The Gambia

Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab

Profile of pediatric Crohn's disease in Belgium

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients

397P R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer

P694 Genetic predisposition and thiopurine-induced pancreatitis in inflammatory bowel disease patients

P603 Persistence of vedolizumab maintenance therapy: Findings from a Belgian registry

P600 Vedolizumab dose optimisation: Findings from a Belgian registry

Budd-Chiari syndrome likely related to a slimming drug preparation

P131 Effectiveness and safety of vedolizumab maintenance therapy for inflammatory bowel disease: findings from a Belgian registry

P495 Efficacy of switching to infliximab in Crohn's disease patients with loss of response to adalimumab

P320 Factors determining therapeutic strategy at diagnosis and evolution of disease severity in a cohort of Belgian pediatric Crohn's disease patients (BELCRO)

P246 Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease

Phase I study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer

A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma

A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma

Immune checkpoint inhibitor refractory colitis leading to total colectomy in a melanoma patient

260 A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma: the RadiOxCape study

Résumés des communications du Groupe Européen de Pathologistes spécialisés en ponctions sous échoendoscopie digestive / Abstracts of European Pathology Group communications on EUS-FNA

Suchergebnisse filtern